Consistently, we found that the overall intracellular mtDNA content in the cells decreased in the treatment of PAN as shown by qPCR analysis (Fig. 5c), supporting that mtDNA is delivered to endolysosomes where it may activate TLR9 while being degraded in the treatment of PAN. The gene discussed is TLR9; the disease is polyarteritis nodosa.